| 发明名称 |
Extending survival of cancer patients with elevated levels of EGF or TGF-alpha |
| 摘要 |
The present application describes extending survival in a cancer patient, where the patient is producing an elevated level of EGF or TGF-alpha, by treating the patient with a HER dimerization inhibitor, such as pertuzumab. |
| 申请公布号 |
AU2007259171(A1) |
申请公布日期 |
2007.12.21 |
| 申请号 |
AU20070259171 |
申请日期 |
2007.05.31 |
| 申请人 |
GENENTECH, INC;F. HOFFMANN-LA ROCHE AG |
发明人 |
ANDREAS STRAUSS;JOACHIM MOECKS;NUSRAT RABBEE;LUKAS C. AMLER |
| 分类号 |
A61K39/00;A61K39/395;C07K16/32 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
